Quantum Biopharma (QNTM) Shares Outstanding (Weighted Average) (2018 - 2026)

Quantum Biopharma's Shares Outstanding (Weighted Average) history runs 9 years deep, the most recent figure standing at $177333.8 billion for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 7065.08% year-over-year to $177333.8 billion; the TTM figure through Mar 2026 stood at $177333.8 billion (up 7065.08% YoY), while the FY2025 annual figure was $3.3 million, down 97.82% from the prior year.
• Shares Outstanding (Weighted Average) came in at $177333.8 billion for Q1 2026 at Quantum Biopharma, up from $169551.0 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $177333.8 billion in Q1 2026 to a low of $390000.0 in Q2 2023.
• A 5-year average of $27868.1 billion and a median of $151.7 billion in 2025 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) plunged 98.43% in 2024 and soared 112794335.9% in 2025, its largest moves.
• Quantum Biopharma's Shares Outstanding (Weighted Average) stood at $143.4 million in 2022, then decreased by 3.93% to $137.8 million in 2023, then increased by 9.1% to $150.3 million in 2024, then jumped by 112794335.9% to $169551.0 billion in 2025, then grew by 4.59% to $177333.8 billion in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $177333.8 billion, $169551.0 billion, and $151.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison